Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden

Nav

General Info

Geography

Sweden (SWE)

Time period covered

01/2008 - 12/2011

Data type

Scientific literature

Keywords

Chemotherapy, Health care costs, Multiple myeloma

Citation

Authors

Borg S, Nahi H, Hansson M, Lee D, Elvidge J, Persson U

Journal

Acta Oncol

Volume

Issue

Pages

554-60

Publication year

2016

Suggested citation

Borg S, Nahi H, Hansson M, Lee D, Elvidge J, Persson U. Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden. Acta Oncol. 2016; 55(5): 554-60.

DOI

10.3109/0284186X.2015.1096021

PMID

27123742

GHDx Entry last modified on: Mar 19, 2021

Header sites

Search form

Main menu

Cost effectiveness of pomalidomide in patients with relapsed and refractory multiple myeloma in Sweden

Nav